AAREY DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.97 Cr | ₹5.78 Cr | ₹4.80 Cr | ₹3.37 Cr | ₹1.46 Cr |
What is the latest Total Non-Current Liabilities ratio of AAREY DRUGS & PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.97 Cr |
Mar2023 | ₹5.78 Cr |
Mar2022 | ₹4.80 Cr |
Mar2021 | ₹3.37 Cr |
Mar2020 | ₹1.46 Cr |
How is Total Non-Current Liabilities of AAREY DRUGS & PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.97 Cr | -31.20 | |
Mar2023 | ₹5.78 Cr | 20.46 | |
Mar2022 | ₹4.80 Cr | 42.24 | |
Mar2021 | ₹3.37 Cr | 131.05 | |
Mar2020 | ₹1.46 Cr | - |
Compare Total Non-Current Liabilities of peers of AAREY DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AAREY DRUGS & PHARMACEUTICALS | ₹180.1 Cr | 10.9% | 2.6% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.8% | -2.7% | 50.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 3.5% | 5.4% | 67.6% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.9% | -1.2% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 2.1% | -3.9% | 6.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 3.3% | -2% | 53.5% | Stock Analytics |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AAREY DRUGS & PHARMACEUTICALS | 10.9% |
2.6% |
31.4% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses